A clinical trial (NCT02848131) suggested that senolytics using a combination of Dasatinib and Quercetin (D + Q) improved physical function in patients with chronic kidney disease (CKD).

Authors

• Person: Not available Organization: Nature
  Cellular rejuvenation: molecular mechanisms and potential ... - Nature

Sources

• Cellular rejuvenation: molecular mechanisms and potential ... - Nature www.nature.com Nature via serper

Referenced by nodes (3)

• Dasatinib concept
• chronic kidney disease concept
• senolytics concept